Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011647 · ClinicalTrials.gov registry record
Prevalence of Sleep Disordered Breathing
A clinical trial, sponsored by GE Healthcare.
- Terminated
- Registry status
- 53
- Enrollment target
NCT01011647: Clinical Trial study, sponsored by GE Healthcare.
NCT01011647 is a clinical trial that was terminated before completion, run by GE Healthcare. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01011647 was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- 53 participants
- Enrollment target
Study Summary
A novel technique in identifying unspecified sleep apnea has been developed. This technique uses signals typical acquired from a bedside monitor that is found in critical care environments. Those signals are then processed by a sleep analysis algorithm to provide an Apnoea Hypopnea Index (AHI) score. This study is intended to determine whether the prevalence of sleep disordered breathing identification among patients in a Coronary Care Unit (CCU) using this novel approach is significantly different than using routine techniques.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-12 |
Why NCT01011647 stopped before completion
NCT01011647 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01011647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01011647 about?
NCT01011647 is a clinical study titled "Prevalence of Sleep Disordered Breathing". A novel technique in identifying unspecified sleep apnea has been developed. This technique uses signals typical acquired from a bedside monitor that is found in critical care environments. Those signals are then processed by a sleep analysis algorithm to provide an Apnoea Hypopnea Index (AHI) score...
What is the current status of trial NCT01011647?
This trial is currently terminated. The enrollment target is 53 participants. The study started on 2009-11. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01011647?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia